Abstract
Background and objective: Cell migration is essential for many biological phenomena with direct impact on human health and disease. One conventional approach to study cell migration involves the quantitative analysis of individual cell trajectories recorded by time-lapse video microscopy. Dedicated software tools exist to assist the automated or semi-automated tracking of cells and translate these into coordinate positions along time. However, cell biologists usually bump into the difficulty of plotting and computing these data sets into biologically meaningful figures and metrics. Methods: This report describes MigraR, an intuitive graphical user interface executed from the RStudio (TM) (via the R package Shiny), which greatly simplifies the task of translating coordinate positions of moving cells into measurable parameters of cell migration (velocity, straightness, and direction of movement), as well as of plotting cell trajectories and migration metrics. One innovative function of this interface is that it allows users to refine their data sets by setting limits based on time, velocity and straightness. Results: MigraR was tested on different data to assess its applicability. Intended users of MigraR are cell biologists with no prior knowledge of data analysis, seeking to accelerate the quantification and visualization of cell migration data sets delivered in the format of Excel files by available cell-tracking software. Conclusions: Through the graphics it provides, MigraR is an useful tool for the analysis of migration parameters and cellular trajectories. Since its source code is open, it can be subject of refinement by expert users to best suit the needs of other researchers. It is available at GitHub and can be easily reproduced.

Abstract
Cardiac auscultation is a key screening tool used for cardiovascular evaluation. When used properly, it speeds up treatment and thus improving the patient's life quality. However, the analysis and interpretation of the heart sound signals is subjective and dependent of the physician's experience and domain knowledge. A computer assistant decision (CAD) system that automatically analyse heart sound signals, can not only support physicians in their clinical decisions but also release human resources to other tasks. In this paper, and to the best of our knowledge, for the first time a SMOTE strategy is used to boost a Convolutional Neural Network performance on the detection of murmur waves. Using the SMOTE strategy, a CNN achieved an overall of 88.43%.

Abstract
Computer Programming Learners usually fail to get approved in introductory courses because solving problems using computers is a complex task. The most important reason for that failure is concerned with motivation; motivation strongly impacts on the learning process. In this paper we discuss how techniques like program animation, and automatic evaluation can be combined to help the teacher in Computer Programming courses. In the article, PEP system will be introduced to explain how it supports teachers in classroom and how it engages students on study sessions outside the classroom. To support that work, students' motivation was studied; to complement that study, a survey involving students attending the first year of Algorithms and Programming course of an Engineering degree was done. It is also presented a tool to analyse surveys, using association rules. © 2022 Paula Correia Tavares et al., published by De Gruyter.

Abstract
Despite the important advances observed, nowadays, the Engineering programmes keep being challenged to better prepare their students to work on complex and multidisciplinary projects while demonstrating awareness of environmental and socio-economic issues and other soft skills as communication and teamwork. Recently, to meet these challenges, the ISEP' Informatics Engineering programme (LEI) successfully adopted a project-based learning approach. In this approach, throughout the entire semester, students develop a real-world project that allows the application and assessment of the competencies taught by all course units of the semester in an integrated, multidisciplinary, and transversal way. In this paper, the authors (i) present this approach as well as the main challenges faced in implementing it; (ii) report the major findings and the perceived benefits and drawbacks; and (iii) discuss the ongoing adaptations and/or others seen as required to improve the approach and its results. © CDIO 2022.All rights reserved.

Abstract
Background: Gene expression studies are an important tool in biological and biomedical research. The signal carried in expression profiles helps derive signatures for the prediction, diagnosis and prognosis of different diseases. Data science and specifically machine learning have many applications in gene expression analysis. However, as the dimensionality of genomics datasets grows, scalable solutions become necessary. Methods: In this paper we review the main steps and bottlenecks in machine learning pipelines, as well as the main concepts behind scalable data science including those of concurrent and parallel programming. We discuss the benefits of the Dask framework and how it can be integrated with the Python scientific environment to perform data analysis in computational biology and bioinformatics. Results: This review illustrates the role of Dask for boosting data science applications in different case studies. Detailed documentation and code on these procedures is made available at https:// github. com/martaccmoreno/gexp-ml-dask. Conclusion: By showing when and how Dask can be used in transcriptomics analysis, this review will serve as an entry point to help genomic data scientists develop more scalable data analysis procedures.

Abstract
AbstractOne of the main obstacles to the successful treatment of cancer is the phenomenon of drug resistance. A common strategy to overcome resistance is the use of combination therapies. However, the space of possibilities is huge and efficient search strategies are required. Machine Learning (ML) can be a useful tool for the discovery of novel, clinically relevant anti-cancer drug combinations. In particular, deep learning (DL) has become a popular choice for modeling drug combination effects. Here, we set out to examine the impact of different methodological choices on the performance of multimodal DL-based drug synergy prediction methods, including the use of different input data types, preprocessing steps and model architectures. Focusing on the NCI ALMANAC dataset, we found that feature selection based on prior biological knowledge has a positive impact on performance. Drug features appeared to be more predictive of drug response. Molecular fingerprint-based drug representations performed slightly better than learned representations, and gene expression data of cancer or drug response-specific genes also improved performance. In general, fully connected feature-encoding subnetworks outperformed other architectures, with DL outperforming other ML methods. Using a state-of-the-art interpretability method, we showed that DL models can learn to associate drug and cell line features with drug response in a biologically meaningful way. The strategies explored in this study will help to improve the development of computational methods for the rational design of effective drug combinations for cancer therapy.Author summaryCancer therapies often fail because tumor cells become resistant to treatment. One way to overcome resistance is by treating patients with a combination of two or more drugs. Some combinations may be more effective than when considering individual drug effects, a phenomenon called drug synergy. Computational drug synergy prediction methods can help to identify new, clinically relevant drug combinations. In this study, we developed several deep learning models for drug synergy prediction. We examined the effect of using different types of deep learning architectures, and different ways of representing drugs and cancer cell lines. We explored the use of biological prior knowledge to select relevant cell line features, and also tested data-driven feature reduction methods. We tested both precomputed drug features and deep learning methods that can directly learn features from raw representations of molecules. We also evaluated whether including genomic features, in addition to gene expression data, improves the predictive performance of the models. Through these experiments, we were able to identify strategies that will help guide the development of new deep learning models for drug synergy prediction in the future.